Iovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC)

Iovance Biotherapeutics announced a conference call and live audio webcast for October 29, 2026, to present positive results from the IOV-LUN-202 Phase 2 registrational cohorts in previously treated nonsquamous mNSCLC.